Light Therapy for
MS Fatigue:
A Research-Driven Approach
Fatigue is one of the most common and limiting symptoms in MS. Multiple phase 1 studies have shown NB-UVB phototherapy to be safe and immune stabilizing for CIS and MS patients. While approved for dermatology, this treatment is investigational for MS and should only be considered in consultation with your medical provider to ensure it is appropriate for your specific needs.
Curious About Light Therapy for MS Fatigue?
Book a free discovery call with a Cytokind Representative — no obligation
“I’m not kidding, this gave me my life back.“
How NB-UVB Light Supports Immune Regulation and Energy
Cytokind, in collaboration with the Kids Research Institute of Australia and Octave BioSciences, Inc., is the first to correlate MS fatigue to inflammation and measure the beneficial effects of NB-UVB.
Measuring Fatigue
Our research used the Fatigue Severity Scale (FSS) — a validated 9-question assessment that captures how fatigue affects daily life in MS patients.
Immune Rebalancing
NB-UVB therapy helps balance the immune response, including reducing inflammation and fatigue. It significantly expanded regulatory T-cells and reduced switch-memory B-cells.
Proven Results
In the PhoCIS trial, FSS scores were significantly correlated with NB-UVB treatment and reduced MS disease activity — offering a non-drug path forward.
Prescribed by Your Care Provider. Supported by Our Team.
We work alongside you and your care provider to make treatment possible at home. Here’s how it works:
Get Informed
Learn about NB-UVB phototherapy and your condition with a 10-minute Discovery Call. No obligation, just answers.
Request a Prescription From Your Care Provider
You and your care provider discuss if phototherapy is right for you. Our team provides supporting clinical resources.
You Receive Your Light and Begin Your Journey
The Cytokind team provides ongoing support — we are with you all the way through your treatment experience.